

Orofacial clefts (OFC) are among the most common birth defects worldwide. The etiology of non-syndromic OFC is still largely unknown. During embryonic development, the cell adhesion molecule E-cadherin, encoded by CDH1, is highly expressed in the median edge epithelium of the palate. Furthermore, in multiple families with CDH1 mutations, OFC cases are observed. To determine whether CDH1 is a causative gene for non-syndromic OFC and to assess whether CDH1 mutation screening in non-syndromic OFC patients enables identification of families at risk of cancer, direct sequencing of the full coding sequence of CDH1 was performed in a cohort of 81 children with non-syndromic OFC. Eleven children had heterozygous CDH1 sequence variants, 5 cases with 4 distinct missense mutations and 8 cases with 4 intronic variants. Using a combination of in silico predictions and in vitro functional assays, three missense mutations in four non-syndromic OFC patients were predicted to be damaging to E-cadherin protein function. The intronic variants including one tested in an in vitro assay appeared to be benign, showing no influence on splicing. Functionally relevant heterozygous CDH1 missense mutations were found in 4 out of 81 (5%) patients with non-syndromic OFC. This finding opens a new pathway to reveal the molecular basis of non-syndromic OFC. Cancer risk among carriers of these mutations needs to be defined. © The Author 2012. Published by Oxford University Press. All rights reserved.
| EMTREE drug terms: | uvomorulin |
|---|---|
| EMTREE medical terms: | articlebirth defectcancer riskcontrolled studygene identificationgene sequencegenetic codegenetic riskgenetic screeninggenetic variabilityheterozygotehumanin vitro studyintronmajor clinical studymissense mutationorofacial cleftpriority journalprotein function |
| MeSH: | AnimalsBrainCadherinsChildChild, PreschoolCHO CellsCleft LipCleft PalateCricetinaeFemaleGenetic Predisposition to DiseaseGerm-Line MutationHeLa CellsHeterozygoteHumansMaleNeoplasmsPedigreePregnancySequence Analysis, DNAStomach Neoplasms |
uvomorulin, 112956-45-3;
CDH1 protein, human; Cadherins
| Funding sponsor | Funding number | Acronym |
|---|---|---|
| Fuel Cell Technologies Program | PTDC/SAU-ONC/ 110294/2009 | FCT |
Part of this work was supported by The Portuguese Foundation for Science and Technology (FCT) (PTDC/SAU-ONC/ 110294/2009).
Hoogerbrugge, N.; Department of Human Genetics, PO Box 9101, Netherlands;
© Copyright 2013 Elsevier B.V., All rights reserved.
© MEDLINE® is the source for the MeSH terms of this document.